The fact that PDGF-CC-induced WAT browning increases glucose tolerance and insulin sensitivity in HFD-induced obese animals suggests that PDGF-CC-induced WAT browning may be considered for treatment of type 2 diabetes in human patients. The gene discussed is INS; the disease is type 2 diabetes mellitus.